Cell-free and cell-bound circulating nucleic acid complexes: mechanisms of generation, concentration and content

Bibliography

• Vlassov VV, Laktionov PP, Rykova EY. Extracellular nucleic acids. Bioessays 2007;29(7):654-67
   PubMed Web of Science ®Google Scholar
• Peters DL, Pretorius PJ. Origin, translocation and destination of extracellular occurring DNA–a new paradigm in genetic behaviour. Clin Chim Acta 2011;412(11-12):806-11
   PubMed Web of Science ®Google Scholar
• Holdenrieder S, Stieber P. Clinical use of circulating nucleosomes. Crit Rev Clin Lab Sci 2009;46(1):1-24
   PubMed Web of Science ®Google Scholar
• Beyer C, Pisetsky DS. The role of microparticles in the pathogenesis of rheumatic diseases. Nat Rev Rheumatol 2010;6(1):21-9
   PubMed Web of Science ®Google Scholar
• Anker P, Mulcahy H, Stroun M, Circulating nucleic acids in plasma and serum as a noninvasive investigation for cancer: time for large-scale clinical studies? Int J Cancer 2003;103:149-52
   PubMed Web of Science ®Google Scholar
• Pisetsky DS, Ullal AJ. The blood nucleome in the pathogenesis of SLE. Autoimmun Rev 2010;10(1):35-7
   PubMed Web of Science ®Google Scholar
• Fleischhacker M, Schmidt B. Circulating nucleic acids (CNAs) and cancer – a survey. Biochim Biophys Acta 2007;1775:181-23
   PubMed Web of Science ®Google Scholar
• Rykova EY, Laktionov PP, Vlassov VV. Circulating nucleic acids in health and disease. Nucleic Acids Mol Biol 2010;25:93-128
   Google Scholar
• Skog J, Wurdinger T, van Rijn S, Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008;10(12):1470-6
   PubMed Web of Science ®Google Scholar
• Garcia-Olmo DC, Dominguez C, Garcia-Arranz M, Cell-free nucleic acids circulating in the plasma of colorectal cancer patients induce the oncogenic transformation of susceptible cultured cells. Cancer Res 2010;70(2):560-7
   PubMed Web of Science ®Google Scholar
• Vlassov VV, Laktionov PP, Rykova EY. Circulating nucleic acids as a potential source for cancer biomarkers. Curr Mol Med 2010;10:142-65
   PubMed Web of Science ®Google Scholar
• Holdenrieder S, Stieber P, Bodenmuller H, Nucleosomes in serum as a marker for cell death. Clin Chem Lab Med 2001;39(7):596-605
   PubMed Web of Science ®Google Scholar
• Gahan PB, Stroun M. The virtosome-a novel cytosolic informative entity and intercellular messenger. Cell Biochem Funct 2010;28(7):529-38
   PubMed Web of Science ®Google Scholar
• Rykova EYu, Pautova LV, Yakubov LA, Serum immunoglobulins interact with oligonucleotides. FEBS Lett 1994;344(1):96-8
   PubMed Web of Science ®Google Scholar
• Chelobanov BP, Laktionov PP, Vlassov VV. Proteins involved in binding and cellular uptake of nucleic acids. Biochemistry 2006;71(6):583-96
   PubMed Web of Science ®Google Scholar
• Zhang W, Wu J, Qiao B, Amelioration of lupus nephritis by serum amyloid P component gene therapy with distinct mechanisms varied from different stage of the disease. PLoS One 2011;6(7):e22659
   PubMed Web of Science ®Google Scholar
• Kragh-Hansen U, Chuang VT, Otagiri M. Practical aspects of the ligand-binding and enzymatic properties of human serum albumin. Biol Pharm Bull 2002;25(6):695-704
   PubMed Web of Science ®Google Scholar
• Pautova LV, Laktionov PP. Rykova EIu, et al. Study of the oligonucleotide binding sites on an immunoglobulin molecule. Mol Biol (Mosk) 1994;28(5):1106-12
   PubMedGoogle Scholar
• Kozyr AV, Gabibov AG. DNA-hydrolyzing Ab: is catalytic activity a clue for physiological significance? Autoimmunity 2009;42(4):359-61
   PubMed Web of Science ®Google Scholar
• Turchinovich A, Weiz L, Langheinz A, Characterization of extracellular circulating microRNA. Nucleic Acids Res 2011;39(16):7223-33
   PubMed Web of Science ®Google Scholar
• Arroyo JD, Chevillet JR, Kroh EM, Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. PNAS 2011;108(12):5003-8
   PubMed Web of Science ®Google Scholar
• Vickers KC, Palmisano BT, Shoucri1 BM, MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 2011;13(4):423-33
   PubMed Web of Science ®Google Scholar
• Gyorgy B, Szabo TG, Pasztoi M, Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci 2011;68(16):2667-88
   PubMed Web of Science ®Google Scholar
• Hugel B, Martinez MC, Kunzelmann C, Membrane microparticles: two sides of the coin. Physiology (Bethesda) 2005;20:22-7
   PubMed Web of Science ®Google Scholar
• Sellam J, Proulle V, Jungel A, Increased levels of circulating microparticles in primary Sjogren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity. Arthritis Res Ther 2009;11(5):R156
   PubMed Web of Science ®Google Scholar
• Laktionov PP, Tamkovich SN, Rykova EY, Cell-surface-bound nucleic acids: free and cell-surface-bound nucleic acids in blood of healthy donors and breast cancer patients. Ann NY Acad Sci 2004;1022:221-7
   PubMed Web of Science ®Google Scholar
• Beliaev ND, Budker VG, Gorokhova OE, Mg2+- dependent interaction of DNA with eukaryotic cells. Mol Biol (Mosk) 1988;22:1667-72
   PubMedGoogle Scholar
• Laktionov PP, Chelobanov BP, Kharkova MV, Cell surface oligonucleotide-binding proteins of human squamous carcinoma A431 cells. Nucleosides Nucleotides Nucleic Acids 2003;22(5-8):1715-19
   PubMed Web of Science ®Google Scholar
• Evans DL, Connor MA, Moss LD, Cellular expression and antimicrobial function of a phylogenetically conserved novel histone 1x-like protein on mouse cells: a potential new class of pattern recognition receptor. J Leukoc Biol 2009;86(1):133-41
   PubMed Web of Science ®Google Scholar
• Irache JM, Merodio M, Amedo A, Albumin nanoparticles for the intravitreal delivery of anticytomegaloviral drugs. Mini Rev Med Chem 2005;5(3):293-305
   PubMed Web of Science ®Google Scholar
• Feinberg EH, Hunter CP. Transport of dsRNA into cells by the transmembrane protein SID-1. Science 2003;301:1545-7
   PubMed Web of Science ®Google Scholar
• Wolfrum C, Mechanisms and optimization of in vivo delivery of lipophilic siRNAs. Nat Biotechnol 2007;25:1149-57
   PubMed Web of Science ®Google Scholar
• Yuan A, Farber EL, Rapoport AL, Transfer of microRNAs by embryonic stem cell microvesicles. PLoS One 2009;4(3):e4722
   PubMed Web of Science ®Google Scholar
• Bergdsmegh A, Ehnforce J, Kawane K, DNase II and the Chk2 DNA damage pathway form a genetic barrier blocking replication of horizontally transferred DNA. Mol Cancer Res 2006;4(3):187-95
   PubMed Web of Science ®Google Scholar
• Morozkin ES, Sil'nikov VN, Rykova EY, Extracellular DNA in culture of primary and transformed cells, infected and not infected with mycoplasma. Bull Exp Biol Med 2009;147(1):63-5
   PubMed Web of Science ®Google Scholar
• Morozkin ES, Laktionov PP, Rykova EY, Extracellular nucleic acids in cultures of long-term cultivated eukaryotic cells. Ann NY Acad Sci 2004;1022:244-9
   PubMed Web of Science ®Google Scholar
• Tamkovich SN, Bryzgunova OE, Rykova EY, Circulating nucleic acids in blood of healthy male and female donors. Clin Chem 2005;51(7):1317-19
   PubMed Web of Science ®Google Scholar
• Kolesnikova EV, Tamkovich SN, Bryzgunova OE, Circulating DNA in the blood of gastric cancer patients. Ann NY Acad Sci 2008;1137:226-31
   PubMed Web of Science ®Google Scholar
• Rykova EY, Wunsche W, Brizgunova OE, Concentrations of circulating RNA from healthy donors and cancer patients estimated by different methods. Ann NY Acad Sci 2006;1075:328-33
   PubMed Web of Science ®Google Scholar
• Tamkovich SN, Litviakov NV, Bryzgunova OE, Cell-surface-bound circulating DNA as a prognostic factor in lung cancer. Ann NY Acad Sci 2008;1137:214-17
   PubMed Web of Science ®Google Scholar
• Goebel G, Zitt M, Zitt M, Circulating nucleic acids in plasma or serum (CNAPS) as prognostic and predictive markers in patients with solid neoplasias. Dis Markers 2005;21:105-20
   PubMed Web of Science ®Google Scholar
• Feng G, Li G, Gentil-Perret A, Elevated serum-circulating RNA in patients with conventional renal cell cancer. Anticancer Res 2008;28:321-6
   PubMed Web of Science ®Google Scholar
• Sueoka K, Nawata S, Nakagawa T, Tumor-associated serpin, squamous cell carcinoma antigen stimulates matrix metalloproteinase-9 production in cervical squamous cell carcinoma cell lines. Int J Oncol 2005;27(5):1345-53
   PubMed Web of Science ®Google Scholar
• Cerkovnik P, Perhavec A, Zgajnar J, Optimization of an RNA isolation procedure from plasma samples. Int J Mol Med 2007;20:293-300
   PubMed Web of Science ®Google Scholar
• Rykova EY, Skvortsova TE, Hoffmann AL, Breast cancer diagnostics based on extracellular DNA and. RNA circulating in blood. Biomed Khim 2008;54:94-103
   PubMedGoogle Scholar
• Tewari M, Mitchell PS. Circulating MicroRNAs in cancer. Nucleic Acids Mol Biol 2010;25:129-46
   Google Scholar
• Dewez B, Lans M, Allaeys V, Serum alkaline deoxyribonuclease activity, a sensitive marker for the therapeutic monitoring of cancer patients: methodological aspects. Eur J Clin Chem Clin Biochem 1993;31(11):793-7
   PubMedGoogle Scholar
• Cherepanova AV, Tamkovich SN, Bryzgunova OE, Deoxyribonuclease activity and circulating DNA concentration in blood plasma of patients with prostate tumors. Ann NY Acad Sci 2008;1137:218-21
   PubMed Web of Science ®Google Scholar
• Phe V, Cussenot O, Roupret M. Methylated genes as potential biomarkers in prostate cancer. BJU Int 2010;105(10):1364-70
   PubMed Web of Science ®Google Scholar
• Barton СA, Hacker NF, Clark SJ, DNA methylation changes in ovarian cancer: implications for early diagnosis, prognosis and treatment. Gynecol Oncol 2008;109:129-39
   Google Scholar
• Radpour R, Kohler C, Haghighi MM, Methylation profiles of 22 candidate genes in breast cancer using high-throughput MALDI-TOF mass array. Oncogene 2009;28:2969-78
   PubMed Web of Science ®Google Scholar
• Korshunova Y, Maloney RK, Lakey N, Massively parallel bisulphite pyrosequencing reveals the molecular complexity of breast cancer-associated cytosine-methylation patterns obtained from tissue and serum DNA. Genome Res 2008;18:19-29
   PubMed Web of Science ®Google Scholar
• Lofton-Day C, Model F, Devos T, DNA methylation biomarkers for blood-based colorectal cancer screening. Clin Chem 2008;54:414-23
   PubMed Web of Science ®Google Scholar
• Kagan J, Srivastava S, Barker PE, Towards clinical application of methylated DNA sequences as cancer biomarkers: a joint NCI's EDRN and NIST workshop on standards, methods, assays, reagents and tools. Cancer Res 2007;67:4545-9
   PubMedGoogle Scholar
• Skvortsova TE, Rykova EY, Tamkovich SN, Cell-free and cell-bound circulating DNA in breast tumours: DNA quantification and analysis of tumour-related gene methylation. Br J Cancer 2006;94(10):1492-5
   PubMed Web of Science ®Google Scholar
• Ponomaryova AA, Rykova EY, Cherdyntseva NV, RARbeta2 gene methylation level in the circulating DNA from blood of patients with lung cancer. Eur J Cancer Prev 2011;20(6):453-5
   PubMed Web of Science ®Google Scholar
• Gahan PB, Stroun M. The biology of circulating nucleic acids in plasma and serum (CNAPS). Nucleic Acids Mol Biol 2010;25:167-90
   Google Scholar
• Morozkin ES, Babochkina TI, Vlassov VV, The effect of protein transport inhibitors on the production of extracellular DNA. Ann NY Acad Sci 2008;1137:31-5
   PubMed Web of Science ®Google Scholar
• Suzuki N, Kamataki A, Yamaki J, Characterization of circulating DNA in healthy human plasma. Clin Chim Acta 2008;387(1-2):55-8
   PubMed Web of Science ®Google Scholar
• Jahr S, Hentze H, Englisch S, DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 2001;61(4):1659-65
   PubMed Web of Science ®Google Scholar
• Morozkin ES, Loseva EM, Mileyko VA, Comparative study of extracellular DNA by FISH. Circulating Nucleic Acids in Plasma and Serum, Gahan PB (ed.), Springer 2011;143-6
   Google Scholar
• Valouev A, Johnson SM, Boyd SD, Determinants of nucleosome organization in primary human cells. Nature 2011;474(7352):516-20
   PubMed Web of Science ®Google Scholar
• Beck J, Urnovitz HB, Mitchell WM, Next generation sequencing of serum circulating nucleic acids from patients with invasive ductal breast cancer reveals differences to healthy and nonmalignant controls. Mol Cancer Res 2010;8(3):335-42
   PubMed Web of Science ®Google Scholar
• Beck J, Urnovitz HB, Riggert J, Profile of the circulating DNA in apparently healthy individuals. Clin Chem 2009;55:730-8
   PubMed Web of Science ®Google Scholar
• van der Vaart M, Semenov DV, Kuligina EV, Characterisation of circulating DNA by parallel tagged sequencing on the 454 platform. Clin Chim Acta 2009;409(1-2):21-7
   PubMed Web of Science ®Google Scholar
• Stroun M, Lyautey J, Lederrey C, Alu repeat sequences are present in increased proportions compared to a unique gene in plasma/serum DNA: evidence for a preferential release from viable cells? Ann NY Acad Sci 2001;945:258-64
   PubMed Web of Science ®Google Scholar
• Ponomaryova AA, Rykova EY, Cherdyntseva NV, Concentration and distribution of single-copy beta-actin gene and LINE-1 repetitive elements in blood of lung cancer patients. Circ Nucleic Acids Plasma Serum 2011;2:41-5
   Google Scholar
• Estecio MR, Gallegos J, Vallot C, Genome architecture marked by retrotransposons modulates predisposition to DNA methylation in cancer. Genome Res 2010;20(10):1369-82
   PubMed Web of Science ®Google Scholar
• Skvortsova TE, Bryzgunova OE, Lebedeva AО, Methylated cell-free DNA in vitro and in vivo. Circ Nucleic Acids Plasma and Serum, Gahan PB (ed.), Springer, 2011;185-94
   Google Scholar
• Roth C, Pantel K, Muller V, Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progression. BMC Cancer 2011;11:4
   PubMed Web of Science ®Google Scholar
• Van der Auwera I, Elst HJ, Van Laere SJ, The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients. Br J Cancer 2009;100:1277-86
   PubMed Web of Science ®Google Scholar
• Schwarzenbach H, Pantel K, Kemper B, Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer. Breast Cancer Res 2009;11(5):R71
   PubMed Web of Science ®Google Scholar
• Kohler C, Radpour R, Barekati Z, Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors. Mol Cancer 2009;8:105
   PubMed Web of Science ®Google Scholar
• Sunami E, Vu AT, Nguyen SL, Quantification of LINE1 in circulating DNA as a molecular biomarker of breast cancer. Ann NY Acad Sci 2008;1137:171-4
   PubMed Web of Science ®Google Scholar
• Seefeld M, El Tarhouny S, Fan AX, Parallel assessment of circulatory cell-free DNA by PCR and nucleosomes by ELISA in breast tumors. Int J Biol Markers 2008;23:69-73
   PubMed Web of Science ®Google Scholar
• El Tarhouny S, Seefeld M, Fan AX, Comparison of serum VEGF and its soluble receptor sVEGFR1 with serum cell-free DNA in patients with breast tumor. Cytokine 2008;44:65-9
   PubMed Web of Science ®Google Scholar
• Zanetti-Dallenbach R, Wight E, Fan AX, Positive correlation of cell-free DNA in plasma/serum in patients with malignant and benign breast disease. Anticancer Res 2008;28:921-5
   PubMed Web of Science ®Google Scholar
• Agostini M, Pucciarelli S, Enzo MV, Circulating cell-Free DNA: a promising marker of pathologic tumor response in rectal cancer patients receiving preoperative chemoradiotherapy. Ann Surg Oncol 2011;18:2461-8
   PubMed Web of Science ®Google Scholar
• Czeiger D, Shaked G, Eini H, Measurement of circulating cell-free DNA levels by a new simple fluorescent test in patients with primary colorectal cancer. Am J Clin Pathol 2011;135:264-70
   PubMed Web of Science ®Google Scholar
• Frattini M, Gallino G, Signoroni S, Quantitative analysis of plasma DNA in colorectal cancer patients: a novel prognostic tool. Ann NY Acad Sci 2006;1075:185-90
   PubMed Web of Science ®Google Scholar
• Zachariah RR, Schmid S, Buerki N, Levels of circulating cell-free nuclear and mitochondrial DNA in benign and malignant ovarian tumors. Obstet Gynecol 2008;112:843-50
   PubMed Web of Science ®Google Scholar
• Gordian E, Ramachandran K, Reis IM, Serum free circulating DNA is a useful biomarker to distinguish benign versus Malignant Prostate disease. Cancer Epidemiol Biomarkers Prev 2010;19:1984-91
   PubMed Web of Science ®Google Scholar
• Schwarzenbach H, Alix-Panabieres C, Muller I, Cancer cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer. Clin Cancer Res 2009;15:1032-8
   PubMed Web of Science ®Google Scholar
• Ellinger J, Bastian PJ, Haan KI, Noncancerous PTGS2 DNA fragments of apoptotic origin in sera of prostate cancer patients qualify as diagnostic and prognostic indicators. Int J Cancer 2008;122:138-43
   PubMed Web of Science ®Google Scholar
• Chun FK, Muller I, Lange I, Circulating tumour-associated plasma DNA represents an independent and informative predictor of prostate cancer. BJU Int 2006;98:544-8
   PubMed Web of Science ®Google Scholar